0001213900-22-063934.txt : 20221013 0001213900-22-063934.hdr.sgml : 20221013 20221013195609 ACCESSION NUMBER: 0001213900-22-063934 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221012 FILED AS OF DATE: 20221013 DATE AS OF CHANGE: 20221013 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: French Anna Louise CENTRAL INDEX KEY: 0001871871 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39138 FILM NUMBER: 221310022 MAIL ADDRESS: STREET 1: C/O QIMING U.S. HEALTHCARE STREET 2: 11100 NE 8TH ST, SUITE 200 CITY: BELLEVUE STATE: WA ZIP: 98004 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jasper Therapeutics, Inc. CENTRAL INDEX KEY: 0001788028 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 842984849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2200 BRIDGE PKWY SUITE #102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 6505491400 MAIL ADDRESS: STREET 1: 2200 BRIDGE PKWY SUITE #102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp DATE OF NAME CHANGE: 20190912 4 1 ownership.xml X0306 4 2022-10-12 0 0001788028 Jasper Therapeutics, Inc. JSPR 0001871871 French Anna Louise C/O JASPER THERAPEUTICS, INC. 2200 BRIDGE PKWY, SUITE #102 REDWOOD CITY CA 94065 1 0 0 0 Voting Common Stock 2022-10-12 4 A 0 30750 0.00 A 30750 D The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. By: /s/ Jeet Mahal, as Attorney-in-Fact 2022-10-13